ProCell Therapies Revenue and Competitors
Estimated Revenue & Valuation
- ProCell Therapies's estimated annual revenue is currently $11.9M per year.
- ProCell Therapies's estimated revenue per employee is $165,764
Employee Data
- ProCell Therapies has 72 Employees.
- ProCell Therapies grew their employee count by 14% last year.
ProCell Therapies's People
Name | Title | Email/Phone |
---|
ProCell Therapies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 13 | 44% | N/A | N/A |
#2 | $14.9M | 73 | -8% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 5 | -37% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 51 | 31% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $1.6M | 9 | 13% | N/A | N/A |
#10 | $16.3M | 80 | -9% | N/A | N/A |
What Is ProCell Therapies?
ProCell Therapies is a leading-edge medical device and biotech/stem cell company in the $6B burdening cosmetic, spa and dermatology space. It has invented a superior device, application method and demonstrated results in generating skin vitality and healing skin injuries. Founded by a Board Certified, Academy of Dermatology MD; top-tier academic and clinical board of advisors.
keywords:N/AN/A
Total Funding
72
Number of Employees
$11.9M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ProCell Therapies News
HydraFacial, LightStim, Minkys, PCA Skin, ProCell Therapies, Repechage, ... directors and managers, estheticians, massage therapists, cosmetologists,...
... Evolv Heated Airbrush Tanning, HydraFacial, LightStim, Minkys, PCA Skin, ProCell Therapies, Repechage, Sorella Apothecary and more.
... Grande Cosmetics, HydraFacial, Lira Clinical, ProCell Therapies, Repechage, ... content and the latest in spa treatments and techniques.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.1M | 72 | -13% | N/A |
#2 | $14.5M | 72 | 4% | N/A |
#3 | $9.3M | 72 | -12% | N/A |
#4 | $22.1M | 72 | -6% | N/A |
#5 | $18.8M | 72 | N/A | N/A |